Transcript of Dr. Bihari Video
00:00 to 02.26—Dr. Bihari gives his background and credentials. Dr. Bihari: My medical training started at Harvard Medical School. I graduated in 1957. Then I trained in Internal Medicine at one of the Harvard teaching hospitals in Boston, Beth Israel, and then in Neurology at Massachusetts General in Boston. Then I went to the National Institutes of Health for two years doing brain physiology—brain research. I did another residency training in Psychiatry in New York, at Columbia Presbyterian Medical Center and then, over the following five or six years, I got very involved in working in Drug Addiction. By 1974, I was the City Addiction Commissioner. I ran all the programs that the city funded for addicts. Then in 1978, the governor and the mayor met, when the governor took over management of the city’s addiction programs, because the city was in a budget crisis. Mayor Koch saved about $8 million and I moved to the city health department as a Deputy Commissioner. I was the only deputy medical commissioner. I basically ran the city health department for about three years. Then I moved to King’s County Hospital, where I ran a cluster of addiction programs for drug addicts and alcoholics. By the early ‘80s, as the AIDS epidemic began, I got very concerned about it. I was seeing large numbers of the heroin addicts I was treating die. I had a couple of friends who died of HIV in the late ‘80s. I got very concerned about what I saw a...
Thousands of Covid-19 patients have been treated with blood plasma outside of rigorous clinical trials — hampering research that would have shown whether the therapy worked.
Might alteration of the gut microbiome by regular use of protein pump inhibitors increase the risk of rheumatoid arthritis in women?Alimentary Pharmacology &Therapeutics
Vaccines protecting against influenza, hepatitis B and rabies are less effective for obese people. As scientists develop a Covid-19 vaccine, experts say obesity could be an impediment, a sobering prospect for the US, where nearly half of all adults are obese.
Publication date: October 2020Source: Multiple Sclerosis and Related Disorders, Volume 45Author(s): Arianna Di Stadio, Massimo Ralli, Marta Altieri, Antonio Greco, Daniela Messineo, Evanthia Bernitsas
SUPPLEMENTS could be used to improve the health of your heart, as well as to protect against high blood pressure symptoms and signs. Add these cheap garlic capsules to your diet to lower your risk of heart problems, including heart attacks and heart disease.
Might HCV treatment have a role in mitigating the risk for developing chronic kidney disease among HIV/HCV co-infected individuals?AIDS
Those suffering from cancer, heart conditions, strokes, diabetes and lung disease are among the worst affected by delays to their diagnosis and care, a survey of senior doctors reveals.
How does sustained virologic response from direct-acting antiviral and interferon-based treatments impact the risk of developing hepatocellular carcinoma?Journal of Viral Hepatitis
[Foroyaa] Unlike HIV/AIDS which is not transmitted by shaking hands, COVID-19 is highly contagious. Inhaling droplets while a person is coughing, sneezing or even talking, if those chatting are in closed, one could become infected. In the same vein, a person could transfer the virus through hand shake.
CONCLUSION: Anti-NMO assays, made available during the last five years with the help of The Guthy-Jackson Charitable Foundation, have led to a clear jump in the number of cases diagnosed. Major advances in the field of epidemiology, imaging, and pathophysiology of NMO-SD have led to improved patient care and outcome. PMID: 32741562 [PubMed - as supplied by publisher]
More News: Addiction | Advertising | Alcoholism | Alopecia | Anxiety | Arthritis | Asthma | Autoimmune Disease | Back Pain | Biotechnology | Brain | Brain Cancers | Breast Cancer | Budgets | Cancer | Cancer & Oncology | Cancer in Adolescents | Cardiology | Cardiovascular | Chemistry | Chemotherapy | Cholesterol | Chronic Pain | Clinical Trials | Colon Cancer | Colorectal Cancer | Contracts | Dementia | Depression | Eczema | Employment | Epidemics | Epidemiology | Funding | Gastroenterology | Genital Herpes | Government | Graduation | Harvard | Head and Neck Cancer | Health | Heart | Heart Failure | Hepatitis | Hepatitis B | Hepatitis C | Herpes | HIV AIDS | Hodgkin's Disease | Hormones | Hospitals | Hypertension | Insomnia | Insurance | Insurers | Internal Medicine | International Medicine & Public Health | Internet | Israel Health | Laboratory Medicine | Learning | Legislation | Liver | Lupus | Lyme Disease | Lymphoma | Melanoma | Methadone | Middle East Health | Morphine | Multiple Sclerosis | National Institutes of Health (NIH) | Neurology | Neuroscience | Non-Hodgkin's Lymphoma | Nurses | Nursing | Nutrition | Orthopaedics | Pain | Pain Management | Pancreas | Pancreatic Cancer | Parasitic Diseases | Parasitology | Prostate Cancer | Psoriasis | Psychiatry | Residencies | Rheumatoid Arthritis | Rheumatology | Schizophrenia | Skin Cancer | Sleep Disorders | Sleep Medicine | Sports Medicine | Statistics | Study | Substance Abuse | Teaching | Teaching Hospitals | Toxicology | Training | Tuberculosis | Uninsured | Universities & Medical Training | Urology & Nephrology | Vitamins | Women